Stock SXTC CHINA SXT PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News China SXT Pharmaceuticals, Inc.

Equities

SXTC

VGG2161P1403

Market Closed - Nasdaq
Other stock markets
 01:30:00 03/05/2024 am IST 		5-day change 1st Jan Change
1.015 USD -0.49% Intraday chart for China SXT Pharmaceuticals, Inc. -5.14% -74.43%
05/04 China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended September 30, 2023 CI
08/02 Wall Street Set to Open Flat Wednesday; Jobless Claims Fall More Than Expected MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
China SXT Pharmaceuticals : MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS - Form 6-K
PU
China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended September 30, 2023
CI
Wall Street Set to Open Flat Wednesday; Jobless Claims Fall More Than Expected
MT
US Futures Marginally Lower Ahead of Jobless Claims, Wholesale Trade Data
MT
Wall Street Set to Open 2024 Lower Amid Rise in Oil Prices, Ahead of Manufacturing, Construction Data
MT
US Equity Futures Set Kick Off 2024 Lower Ahead of Manufacturing PMI, Construction Data
MT
China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule
AQ
China SXT Pharmaceuticals to Implement 1-for-25 Reverse Stock Split
MT
China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split
AQ
China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
CI
China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule
AQ
China SXT Pharmaceuticals : Purchase Agreement - Form 6-K
PU
China SXT Pharmaceuticals, Inc. announced that it has received $2 million in funding from Streeterville Capital, LLC
CI
China SXT Pharmaceuticals : Securities Purchase Agreement - Form 6-K
PU
China SXT Pharmaceuticals : MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS - Form 6-K
PU
China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended September 30, 2022
CI
China SXT Pharmaceuticals : Securities Purchase Agreement - Form 6-K
PU
China SXT Pharmaceuticals, Inc. announced that it has received $1.5 million in funding from Streeterville Capital, LLC
CI
China SXT Pharmaceuticals, Inc. announced that it expects to receive $1.5 million in funding from Streeterville Capital, LLC
CI
Top Premarket Gainers
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SXTC Stock
  4. News China SXT Pharmaceuticals, Inc.